As a rutin derivative, troxerutin was capable of reducing the expression of GnRH (as the master hormone), reducing the secretion of LH and testosterone, and improving the reproductive endocrine dysfunction of 5α-DHT-induced PCOS rats (Gao et al., 2020). The gene discussed is PLOD1; the disease is polycystic ovary syndrome.